Cart
sales@molnova.com
Home -
Products -
Membrane Transporter/Ion Channel -
Carbonic Anhydrase -
Methyl 2,4-dihydroxybenzoate
Methyl 2,4-dihydroxybenzoate
CAS No. 2150-47-2
Methyl 2,4-dihydroxybenzoate( —— )
Catalog No. M23976 CAS No. 2150-47-2
Methyl 2,4-dihydroxybenzoate is a natural product.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 28 | In Stock |
|
| 25MG | 32 | In Stock |
|
| 50MG | 43 | In Stock |
|
| 100MG | 60 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 129 | In Stock |
|
| 1G | 184 | In Stock |
|
Biological Information
-
Product NameMethyl 2,4-dihydroxybenzoate
-
NoteResearch use only, not for human use.
-
Brief DescriptionMethyl 2,4-dihydroxybenzoate is a natural product.
-
DescriptionMethyl 2,4-dihydroxybenzoate is a natural product.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMembrane Transporter/Ion Channel
-
TargetCarbonic Anhydrase
-
RecptorCarbonic anhydrase II
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2150-47-2
-
Formula Weight168.15
-
Molecular FormulaC8H8O4?
-
Purity>98% (HPLC)
-
SolubilityDMSO:10 mM
-
SMILESCOC(=O)C1=C(C=C(C=C1)O)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Disulfamide
Disulfamide is an orally active carbonic anhydrase inhibitor with an IC50 value of 0.07 μM. Disulfamide has a diuretic effect by inhibiting carbonic anhydrase and preventing the reabsorption of sodium and bicarbonate in the proximal convoluted tubules.
-
hCAI/II-IN-6
hCAI/II-IN-6 is a selective and orally active inhibitor of human carbonic anhydrase (CA). hCAI/II-IN-6 inhibited hCA I, hCA II, hCA VII, and hCA XII with Ki values of 220, 4.9, 6.5, and ＞50,000 nM.
-
Acetazolamide sodium
Acetazolamide sodium (OT-302 sodium) is a potent carbonic anhydrase (CA)IX inhibitor with diuretic, antigonococcal, and antihypertensive activity and may be used for indications such as epilepsy, glaucoma, edema, and altitude sickness.
